Perkins Capital Management Inc Tela Bio, Inc. Transaction History

Perkins Capital Management Inc

$102 Million
Q3 2024

A detailed history of Perkins Capital Management Inc transactions in Tela Bio, Inc. stock. As of the latest transaction made, Perkins Capital Management Inc holds 225,200 shares of TELA stock, worth $621,552. This represents 0.56% of its overall portfolio holdings.

Number of Shares

225,200

Previous 204,350 10.2%

Holding current value

$621,552

Previous $960,000 40.73%

% of portfolio

0.56%

Previous 0.95%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$2.32 - $5.04 $48,372 - $105,084	20,850 Added 10.2%	225,200 $569,000
Q2 2024 Aug 09, 2024	SELL	$4.39 - $6.36 $24,803 - $35,934	-5,650 Reduced 2.69%	204,350 $960,000
Q1 2024 May 09, 2024	SELL	$5.3 - $7.61 $1,325 - $1,902	-250 Reduced 0.12%	210,000 $1.19 Million
Q4 2023 Jan 22, 2024	BUY	$4.5 - $7.51 $88,875 - $148,322	19,750 Added 10.37%	210,250 $1.39 Million
Q2 2023 Jul 21, 2023	BUY	$9.23 - $11.23 $221,520 - $269,520	24,000 Added 14.41%	190,500 $1.93 Million
Q1 2023 May 09, 2023	SELL	$9.41 - $12.03 $63,517 - $81,202	-6,750 Reduced 3.9%	166,500 $1.77 Million
Q4 2022 Jan 26, 2023	SELL	$6.5 - $11.5 $3,250 - $5,750	-500 Reduced 0.29%	173,250 $1.99 Million
Q3 2022 Oct 24, 2022	BUY	$7.36 - $9.15 $1.28 Million - $1.59 Million	173,750 New	173,750 $1.48 Million
Q1 2021 Apr 28, 2021	SELL	$12.84 - $17.26 $141,240 - $189,860	-11,000 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$14.61 - $17.59 $160,710 - $193,490	11,000 New	11,000 $165,000
Q3 2020 Oct 28, 2020	SELL	$11.64 - $16.86 $116,400 - $168,600	-10,000 Closed	0 $0
Q4 2019 Feb 03, 2020	BUY	$11.26 - $13.8 $112,600 - $138,000	10,000 New	10,000 $130,000

Others Institutions Holding TELA

# of Institutions

Shares Held

18.3M

Call Options Held

759K

Put Options Held

100

View Full List

About TELA Bio, Inc.

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $52.9M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

More about TELA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.

Account

Perkins Capital Management Inc Tela Bio, Inc. Transaction History